These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17634128)

  • 21. Modulation by presynaptic adenosine A1 receptors of nicotinic receptor antagonist-induced neuromuscular block in the mouse.
    Prior C; Breadon EL; Lindsay KE
    Eur J Pharmacol; 1997 May; 327(2-3):103-8. PubMed ID: 9200547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pharmacodynamic basis for the peak effect of vecuronium: peak twitch versus peak tetanic fade.
    Tripathi M; Tripathi M
    J Indian Med Assoc; 2002 Aug; 100(8):491-2, 494, 501. PubMed ID: 12675179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the train-of-four response in fast and slow muscles: effect of d-tubocurarine, pancuronium, and vecuronium.
    Day NS; Blake GJ; Standaert FG; Dretchen KL
    Anesthesiology; 1983 May; 58(5):414-7. PubMed ID: 6132567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twitch augmentation and train-of-four fade during onset of neuromuscular block after subclinical doses of suxamethonium.
    Kim SY; Lee JS; Kim SC; Park W
    Br J Anaesth; 1997 Sep; 79(3):379-81. PubMed ID: 9389859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
    Ploeger BA; Smeets J; Strougo A; Drenth HJ; Ruigt G; Houwing N; Danhof M
    Anesthesiology; 2009 Jan; 110(1):95-105. PubMed ID: 19104176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromuscular blocking characteristics of vecuronium after tubocurarine-induced "fade". An experimental double-blind clinical study.
    Puura A; Baer GA; Rorarius MG
    Eur J Clin Pharmacol; 1999 May; 55(3):173-6. PubMed ID: 10379631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examination of the mechanisms involved in tetanic fade produced by vecuronium and related analogues in the rat diaphragm.
    Gibb AJ; Marshall IG
    Br J Pharmacol; 1987 Mar; 90(3):511-21. PubMed ID: 2882802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective doses of vecuronium in a patient with myotonic dystrophy.
    Nishi M; Itoh H; Tsubokawa T; Taniguchi T; Yamamoto K
    Anaesthesia; 2004 Dec; 59(12):1216-8. PubMed ID: 15549982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of nicorandil on the neuromuscular block induced by vecuronium].
    Oyanagi S; Matsuda T; Abe H; Mori H
    Masui; 1995 Jul; 44(7):986-9. PubMed ID: 7637190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling of twitch fade based on slow interaction of nondepolarizing muscle relaxants with the presynaptic receptors.
    Bhatt SB; Amann A; Nigrovic V
    J Pharmacokinet Pharmacodyn; 2006 Aug; 33(4):461-83. PubMed ID: 16752087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of tetanus on subsequent neuromuscular monitoring in patients receiving vecuronium.
    Brull SJ; Connelly NR; O'Connor TZ; Silverman DG
    Anesthesiology; 1991 Jan; 74(1):64-70. PubMed ID: 1670914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of vecuronium bromide.
    Nomura T
    J Anesth; 1992 Jan; 6(1):28-37. PubMed ID: 15278580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propofol potentiates both pre- and postsynaptic effects of vecuronium in the rat hemidiaphragm.
    Lebeda MD; Wegrzynowicz ES; Wachtel RE
    Br J Anaesth; 1992 Mar; 68(3):282-5. PubMed ID: 1347685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual non-depolarising neuromuscular block assessed by train-of-four stimulation in the dog.
    Cullen LK; Jones RS
    Res Vet Sci; 1982 Jan; 32(1):121-3. PubMed ID: 7089375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Train-of-four fade during onset and recovery of neuromuscular block: a study in non-anaesthetized subjects.
    Turner GA; Williams JD; Baker DJ
    Br J Anaesth; 1989 Mar; 62(3):279-86. PubMed ID: 2564783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of the neuromuscular blockade levels on amplitudes of posttetanic motor-evoked potentials and movement in response to transcranial stimulation in patients receiving propofol and fentanyl anesthesia.
    Yamamoto Y; Kawaguchi M; Hayashi H; Horiuchi T; Inoue S; Nakase H; Sakaki T; Furuya H
    Anesth Analg; 2008 Mar; 106(3):930-4, table of contents. PubMed ID: 18292442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovery of neuromuscular blockade caused by vecuronium is delayed in patients with hypertriglyceridemia.
    Saitoh Y; Oshima T; Nakata Y
    J Anesth; 2008; 22(1):89-92. PubMed ID: 18306024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic analysis of the effect of vecuronium in surgical patients: pharmacokinetic and pharmacodynamic modeling without plasma concentrations.
    Warwick NR; Graham GG; Torda TA
    Anesthesiology; 1998 Apr; 88(4):874-84. PubMed ID: 9579494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of tetanic stimulation on subsequent train-of-four responses at various levels of vecuronium-induced neuromuscular block.
    Saitoh Y; Masuda A; Toyooka H; Amaha K
    Br J Anaesth; 1994 Sep; 73(3):416-7. PubMed ID: 7946873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of voluntary tetanus on recovery of vecuronium block in the isolated forearm.
    Gopinath S; Hood JR; Ul-Haq M; Campkin NT; Feldman SA
    Anaesthesia; 1993 Oct; 48(10):870-2. PubMed ID: 7902025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.